Rahul Banerjee, Assistant Professor at UW Medicine, shared on X:
“Great Blood Cancer work by , et al! How different BCMA Treatment fare in Multiple myeloma. Zooming in on 4th figure in Bob’s summary: for true EMD (visceral), MRD-neg BMBx not enough. Scan often, and I reach early for tal +/- pom after any hint of BCMA CAR-T failure here.”
Clinical features associated with poor response and early relapse following BCMA-directed therapies in multiple myeloma
Autors: Matthew J Rees, Aytaj Mammadzadeh, Abiola Bolarinwa, Mohammed E Elhaj, Arwa Bohra, Radhika Bansal, Sikander Ailawadhi, Ricardo Parrondo, Saurabh Chhabra, Amit Khot, Suzanne Hayman, Angela Dispenzieri, Francis Buadi, David Dingli, Rahma Warsame, Prashant Kapoor, Morie A Gertz, Eli Muchtar, Taxiarchis Kourelis, Wilson Gonsalves, S Vincent Rajkumar, Yi Lin, Shaji Kumar
Source: Rahul Banerjee/X